The Cooperative Expression of the Solute Carriers, SLC1A5, SLC7A5 and SLC3A2, Confers a Poor Prognosis in the Highly Proliferative ER plus Breast Cancer Subtype

被引：0
|
作者：
El Ansari, R. [1 ]
Craze, M. L. [1 ]
Soria, D. [2 ]
Diez-Rodriguez, M. [1 ]
Nolan, C. C. [1 ]
Ellis, I. O. [1 ]
Rakha, E. A. [1 ]
Green, A. R. [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
[2] Univ Westminster, London, England
来源：
JOURNAL OF PATHOLOGY | 2018年 / 246卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] ENHANCING ANTI-TUMOR IMMUNOTHERAPY BY TARGETING THE AMINO ACID TRANSPORTERS SLC1A5 AND SLC3A2/SLC7A5
    Nachef, M.
    Lee, S. H.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 4) : S129 - S130
  • [2] Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
    Nachef, Marianna
    Ali, Alaa Kassim
    Almutairi, Saeedah Musaed
    Lee, Seung-Hwan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
    El Ansari, Rokaya
    Craze, Madeleine L.
    Diez-Rodriguez, Maria
    Nolan, Christopher C.
    Ellis, Ian O.
    Rakha, Emad A.
    Green, Andrew R.
    BRITISH JOURNAL OF CANCER, 2018, 118 (08) : 1115 - 1122
  • [4] The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
    Rokaya El Ansari
    Madeleine L. Craze
    Maria Diez-Rodriguez
    Christopher C. Nolan
    Ian O. Ellis
    Emad A. Rakha
    Andrew R. Green
    British Journal of Cancer, 2018, 118 : 1115 - 1122
  • [5] Glutamine Transporters SLC1A5 and SLC7A5 are Key Therapeutic Targets in Luminal B Breast Cancer
    El-Ansari, R.
    Aleskandarany, M. A.
    Cheng, K. W.
    Diez-Rodriguez, M.
    Nolan, C. C.
    Caldas, C.
    Ellis, I. O.
    Rakha, E. A.
    Green, A. R.
    JOURNAL OF PATHOLOGY, 2017, 243 : S16 - S16
  • [6] Prognostic and Predictive Value of Amino Acid Transporters SLC7A5 and SLC3A2 Co-Expression in Breast Cancer
    El Ansari, R.
    Alfarsi, L. H.
    Craze, M. L.
    Diez-Rodriguez, M.
    Nolan, C. C.
    Ellis, I. O.
    Rakha, E. A.
    Green, A. R.
    JOURNAL OF PATHOLOGY, 2019, 248 : S9 - S9
  • [7] The role of amino acid transporters SLC1A5 and SLC3A2 in primary breast cancer in older women
    Parks, Ruth
    Alfarsi, Lutfi
    Green, Andrew
    Cheung, Kwok-Leung
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [8] Downregulation of LAT1 (SLC7A5) and ASCT2 (SLC1A5) in human cancer.
    Oliveira, A.
    Carneiro, C.
    Serrao, P.
    Kennedy, P.
    Soares-da-Silva, P.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [9] The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours
    El Ansari, Rokaya
    Craze, Madeleine L.
    Miligy, Islam
    Diez-Rodriguez, Maria
    Nolan, Christopher C.
    Ellis, Ian O.
    Rakha, Emad A.
    Green, Andrew R.
    BREAST CANCER RESEARCH, 2018, 20
  • [10] The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours
    Rokaya El Ansari
    Madeleine L. Craze
    Islam Miligy
    Maria Diez-Rodriguez
    Christopher C. Nolan
    Ian O. Ellis
    Emad A. Rakha
    Andrew R. Green
    Breast Cancer Research, 20
12345